HXL Hexima Limited
—Mkt Cap: —P/E: —1d ago
Hexima Limited does not have significant operations. It focuses on exploration of transactions with third parties, which could enable the value of the company's assets. Previously, the company was involved in the researc…
Industry Peers
Biotechnology$128.87BUSDP/E 29.6
$94.42BUSD
$81.99BUSDP/E 19.1
$53.47BUSDP/E 32.5
$53.22BUSDP/E 31.6
$44.02BUSDP/E 17.8
$42.56BUSDP/E 66.4
$40.57BUSD
$34.45BUSDP/E 30.4
$31.32BUSDP/E 39.3
$24.59BUSD
$23.32BUSDP/E 31.7
$23.26BUSDP/E 29.8
$22.96BUSDP/E 14.0
$22.66BUSD
$21.67BUSD
$15.57BUSDP/E 19.3
$14.91BUSDP/E 17.4
$13.92BUSDP/E 14.7
$13.79BUSDP/E 33.4
Key Statistics
Company
Market Cap—
Enterprise Value1.32M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-154.60K USD
Revenue/Share—
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU0000111932
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B2.17
EPS (TTM)-0.02
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-25.53%
ROA-17.97%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-185.13K USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-178.52K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio7.00
Quick Ratio6.70
Book Value/Sh0.0060 AUD
Cash/Share0.0060 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div DateApr 21, 2026
Pay Date—
Splits
Last Split1:4
Split DateApr 21, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.41.76M
Float18.92M
Insiders64.10%
Institutions0.00%
Technical
SMA 500.0520 AUD
SMA 2000.0391 AUD
Beta0.87
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)0
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—